Trials / Completed
CompletedNCT00374790
Iron Supplementation of Lead-exposed Infants
Pilot Study to Determine the Efficacy of Iron Supplementation in Preventing the Elevation of Blood Lead Concentrations in Young Children
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Cornell University · Academic / Other
- Sex
- All
- Age
- 6 Months – 18 Months
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to compare the efficacy of iron (12.5 mg as ferrous sulfate) and placebo given for 6 months in preventing the elevation of blood lead concentration in children 6-9 months of age.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ferrous sulfate |
Timeline
- Start date
- 2006-10-01
- Primary completion
- 2008-05-01
- Completion
- 2008-07-01
- First posted
- 2006-09-11
- Last updated
- 2018-05-15
Locations
1 site across 1 country: Uruguay
Source: ClinicalTrials.gov record NCT00374790. Inclusion in this directory is not an endorsement.